Live Breaking News & Updates on Medicines Stock Down

Stay updated with breaking news from Medicines stock down. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Bellevue Group AG Boosts Stock Holdings in Revolution Medicines, Inc. (NASDAQ:RVMD)

Bellevue Group AG boosted its position in Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) by 7.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 5,091,000 shares of the company’s stock after purchasing an additional 369,500 shares during the period. Revolution Medicines […] ....

Jack Anders , Raymond James , Jeff Cislini , Piper Sandler , Bellevue Group , Revolution Medicines Inc , Exchange Commission , Securities Exchange Commission , Bain Capital Life Sciences Investors , Rafferty Asset Management , Investment Management , Revolution Medicines , Free Report , Fire Capital , Point Capital , Capital Life Sciences Investors , Asset Management , Medicines Stock Down , Get Free Report , General Counsel Jeff Cislini , Visit Holdingschannel , Revolution Medicines Daily ,

Short Interest in Blueprint Medicines Co. (NASDAQ:BPMC) Grows By 6.8%

Blueprint Medicines Co. (NASDAQ:BPMC – Get Free Report) was the recipient of a significant growth in short interest in April. As of April 30th, there was short interest totalling 4,540,000 shares, a growth of 6.8% from the April 15th total of 4,250,000 shares. Based on an average trading volume of 830,500 shares, the days-to-cover ratio […] ....

United States , Christopherk Murray , Piper Sandler , Stifel Nicolaus , Blueprint Medicines Co , Needham Company , Principal Financial Group Inc , Us Bancorp , Associates Corp , Mirae Asset Global Investments Co , Blueprint Medicines Company Profile , Securities Exchange Commission , Canada Life Assurance , Blueprint Medicines Corporation , Blueprint Medicines , Get Free Report , Exchange Commission , Asset Global Investments , Financial Group , Medicines Stock Down , Medicines Corporation , Blueprint Medicines Daily ,

Blueprint Medicines Co. (NASDAQ:BPMC) CFO Sells $1,050,000.00 in Stock

Blueprint Medicines Co. (NASDAQ:BPMC – Get Free Report) CFO Michael Landsittel sold 10,000 shares of the business’s stock in a transaction that occurred on Thursday, May 2nd. The shares were sold at an average price of $105.00, for a total value of $1,050,000.00. Following the transaction, the chief financial officer now owns 47,286 shares of […] ....

United States , Michael Landsittel , Blueprint Medicines Company Profile , Polar Capital Holdings Plc , Blueprint Medicines Co , Norges Bank , Goldman Sachs Group , Needham Company , Blueprint Medicines Corporation , Blueprint Medicines , Get Free Report , Medicines Stock Down , Capital Holdings Plc , Springs Capital Management , Partners Management , Medicines Corporation , Blueprint Medicines Daily , Nasdaq Bpmc , Insider Trading , Nsider Trades ,

Blueprint Medicines (NASDAQ:BPMC) Earns "Buy" Rating from HC Wainwright

Blueprint Medicines (NASDAQ:BPMC) Earns "Buy" Rating from HC Wainwright
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United States , Christopherk Murray , Stifel Nicolaus , Michael Landsittel , Polar Capital Holdings Plc , Needham Company , Securities Exchange Commission , Blueprint Medicines Corporation , Norges Bank , Blueprint Medicines , Get Free Report , Medicines Stock Down , Exchange Commission , Capital Holdings Plc , Springs Capital Management , Partners Management , Medicines Corporation , Blueprint Medicines Daily ,